Skip to content
All news
Data + AI FoundationsDatabricks Blog·July 24, 2026·Databricks Staff

AI in supply chain: from demand forecasting to AI agents

Summary

Accelerating clinical AI adoption across diagnostics, documentation, and drug discovery faces tightening regulatory scrutiny as the European AI Act will classify most clinical systems as high-risk by 2026. Successfully navigating these mandates alongside HIPAA requires teams to anchor deployments in human oversight, bias-tested training data, and staged validation to safely augment clinical judgment.

Summary generated by brickster.ai. For the full article, follow the source link above.

More from Databricks Blog